Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
The American Surgeon|May 17, 2024
Epiploic Appendagitis: Systematic Review of a Distinctive PathologyCarlos D Acevedo-Castillo, Hannia M Macias-Cruz, Arantxa Ramirez-Cisneros, et al.Nature Communications|April 22, 2020
Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapyClayton Hardman, Stephen Ho, Akira Shimizu, et al.Molecular Therapy. Nucleic Acids|February 18, 2015
RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT MiceSaki Shimizu, Gene-Errol Ringpis, Matthew D Marsden, et al.Proceedings of the National Academy of Sciences of the United States of America|July 2, 2013
Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivoElizabeth J Beans, Dennis Fournogerakis, Carolyn Gauntlett, et al.Plos One|September 17, 2015
Disruption of Type I Interferon Induction by HIV Infection of T CellsDavid Jesse Sanchez, Daniel Miranda, Matthew D Marsden, et al.ACS Nano|July 26, 2014
Bioengineered vaults: self-assembling protein shell-lipophilic core nanoparticles for drug deliveryDaniel C Buehler, Matthew D Marsden, Sean Shen, et al.The Journal of Clinical Investigation|February 11, 2025
Rapamycin enhances CAR-T control of HIV replication and reservoir elimination in vivoWenli Mu, Shallu Tomer, Jeffrey Harding, et al.Cell Reports. Medicine|December 30, 2020
Tracking HIV Rebound following Latency Reversal Using Barcoded HIVMatthew D Marsden, Tian-Hao Zhang, Yushen Du, et al.Proceedings of the National Academy of Sciences of the United States of America|May 7, 2020
Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic windowJack L Sloane, Nancy L Benner, Katherine N Keenan, et al.Biorxiv : the Preprint Server for Biology|February 6, 2026
Leveraging HIV-Specific CAR T Cells and Rapamycin Treatment in "Kick-and-Kill" HIV Cure ApproachesNishad S Maggirwar, José A Morán, Wenli Mu, et al.Pageof 6